Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
Clinical trial NCT05296512 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05296512
- Sponsor
- Elizabeth K. Lee MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2026-09-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.